Patten & Patten Inc Amgen Inc Transaction History

Patten & Patten Inc

$1.39 Billion
Q1 2024

A detailed history of Patten & Patten Inc transactions in Amgen Inc stock. As of the latest transaction made, Patten & Patten Inc holds 3,104 shares of AMGN stock, worth $964,971. This represents 0.06% of its overall portfolio holdings.

Number of Shares

3,104

Previous 2,968 4.58%

Holding current value

$964,971

Previous $854,000 3.28%

% of portfolio

0.06%

Previous 0.07%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$268.87 - $324.56 $36,566 - $44,140	136 Added 4.58%	3,104 $882,000
Q4 2023 Jan 23, 2024	BUY	$255.7 - $288.46 $34,008 - $38,365	133 Added 4.69%	2,968 $854,000
Q3 2023 Oct 27, 2023	SELL	$218.65 - $271.46 $43,292 - $53,749	-198 Reduced 6.53%	2,835 $761,000
Q2 2023 Jul 14, 2023	SELL	$214.27 - $253.37 $70,280 - $83,105	-328 Reduced 9.76%	3,033 $673,000
Q1 2023 Apr 25, 2023	SELL	$225.79 - $275.2 $10,837 - $13,209	-48 Reduced 1.41%	3,361 $812,000

Q4 2022 Feb 01, 2023	SELL	$229.03 - $291.01 $68,250 - $86,720	-298 Reduced 8.04%	3,409 $895,000
Q3 2022 Oct 19, 2022	SELL	$224.46 - $253.15 $1,795 - $2,025	-8 Reduced 0.22%	3,707 $836,000
Q2 2022 Aug 02, 2022	SELL	$230.71 - $256.74 $51,448 - $57,253	-223 Reduced 5.66%	3,715 $904,000
Q1 2022 Apr 25, 2022	SELL	$219.27 - $242.57 $3,508 - $3,881	-16 Reduced 0.4%	3,938 $952,000
Q4 2021 Jan 26, 2022	BUY	$198.88 - $227.6 $3,977 - $4,552	20 Added 0.51%	3,954 $890,000
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $134,154 - $157,178	-632 Reduced 13.84%	3,934 $837,000
Q2 2021 Jul 13, 2021	BUY	$233.58 - $259.14 $208,586 - $231,412	893 Added 24.31%	4,566 $1.11 Million
Q1 2021 Apr 23, 2021	BUY	$221.91 - $258.6 $29,957 - $34,911	135 Added 3.82%	3,673 $914,000
Q4 2020 Jan 19, 2021	BUY	$216.38 - $257.67 $43,492 - $51,791	201 Added 6.02%	3,538 $814,000
Q3 2020 Oct 08, 2020	SELL	$234.65 - $260.95 $22,995 - $25,573	-98 Reduced 2.85%	3,337 $848,000
Q2 2020 Jul 21, 2020	BUY	$197.81 - $242.74 $32,440 - $39,809	164 Added 5.01%	3,435 $810,000
Q1 2020 Apr 16, 2020	SELL	$182.24 - $241.7 $60,503 - $80,244	-332 Reduced 9.21%	3,271 $663,000
Q4 2019 Jan 13, 2020	BUY	$189.21 - $243.2 $103,308 - $132,787	546 Added 17.86%	3,603 $868,000
Q3 2019 Oct 15, 2019	BUY	$174.11 - $208.62 $124,662 - $149,371	716 Added 30.59%	3,057 $592,000
Q2 2019 Jul 11, 2019	SELL	$166.7 - $195.41 $41,008 - $48,070	-246 Reduced 9.51%	2,341 $431,000
Q1 2019 Apr 23, 2019	BUY	$180.87 - $203.88 $9,043 - $10,194	50 Added 1.97%	2,587 $491,000
Q4 2018 Jan 17, 2019	SELL	$178.4 - $208.25 $41,745 - $48,730	-234 Reduced 8.44%	2,537 $494,000
Q3 2018 Oct 17, 2018	SELL	$185.29 - $208.89 $13,526 - $15,248	-73 Reduced 2.57%	2,771 $574,000
Q2 2018 Jul 18, 2018	BUY	$166.05 - $186.51 $332 - $373	2 Added 0.07%	2,844 $525,000
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $33,716 - $39,402	-199 Reduced 6.54%	2,842 $485,000
Q4 2017 Jan 22, 2018	SELL	$168.79 - $188.59 $16,710 - $18,670	-99 Reduced 3.15%	3,041 $529,000
Q3 2017 Oct 12, 2017	BUY	$167.29 - $191.0 $525,290 - $599,740	3,140	3,140 $585,000

Others Institutions Holding AMGN

# of Institutions

2,933

Shares Held

401M

Call Options Held

6.59M

Put Options Held

6.6M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $166B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Patten & Patten Inc, based on Form 13F filings with the SEC.

News

Stay updated on Patten & Patten Inc with notifications on news.

Account

Patten & Patten Inc Amgen Inc Transaction History